| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10588874 | Bioorganic & Medicinal Chemistry Letters | 2010 | 5 Pages | 
Abstract
												Synthesis and structure-activity relationships of cannabinoid-1 receptor (CB1R) inverse agonists based on dihydro-pyrano[2,3-b] pyridine and tetrahydro-1,8-naphtyridine scaffolds are presented. Rat food intake and pharmacokinetic evaluation of 13g, 13i, 13k and 17a revealed these compounds to be highly efficacious orally active modulators of CB1R.
											Related Topics
												
													Physical Sciences and Engineering
													Chemistry
													Organic Chemistry
												
											Authors
												Christina B. Madsen-Duggan, John S. Debenham, Thomas F. Walsh, Lin Yan, Pei Huo, Junying Wang, Xinchun Tong, Julie Lao, Tung M. Fong, Jing Chen Xiao, Cathy R.-R.C. Huang, Chun-Pyn Shen, D.Sloan Stribling, Lauren P. Shearman, Alison M. Strack, 
											![First Page Preview: Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: Synthesis, SAR and biological evaluation Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: Synthesis, SAR and biological evaluation](/preview/png/10588874.png)